Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).

21 C.F.R. § 341.70
in effectEffective: 2024-07-01
Sign in to generate a plain English summaryAsk Belisarius Agent